Syngenta Anticipates Minimal Impact from US Tariffs on Business by 2025
ByAinvest
Tuesday, Jun 10, 2025 12:11 pm ET1min read
BIOA--
The agricultural biologics market is projected to reach $16.61 billion in 2025, with a compound annual growth rate (CAGR) of 16.0% expected to push this value further to $29.92 billion by 2029 [2]. The growth is driven by factors such as the rise in organic farming practices, heightened awareness of the environmental impact of heavy chemical pesticide and fertilizer use, and an increase in the global population.
Syngenta, like many other major players in the agricultural biologics market, is actively innovating and introducing sustainable solutions. For instance, UK-based biotech firm Bionema UK launched the Biodegradable Surfactant Soil-Jet BSP100 in January 2024, which enhances the efficacy of biological and chemical products while minimizing environmental damage [2].
Despite the investments in biological products, Syngenta's operations are not expected to be significantly affected by the US tariffs. The company's focus on innovation and sustainability aligns with broader trends in the agricultural sector, where there is a growing preference for environmentally friendly solutions.
References:
[1] https://www.business-humanrights.org/en/latest-news/kenya-eu-based-companies-continue-to-export-banned-pesticides-exposing-communities-workers-to-chemical-burns-and-long-term-illness/
[2] https://menafn.com/1109644592/Global-Agricultural-Biologics-Market-Forecast-Key-Growth-Drivers-Trends-And-Opportunities-From-2025-To-2034
Syngenta expects minimal impact from US tariffs on its business in 2025. The company is expanding and investing in biological products, but they do not replace synthetic agricultural chemicals. The tariffs imposed by US President Donald Trump are expected to have a limited effect on Syngenta's operations.
Syngenta, a leading global agribusiness company, expects minimal impact from the US tariffs imposed by President Donald Trump on its business operations in 2025. The company has been expanding and investing in biological products, a sector that is witnessing significant growth due to increasing awareness of the environmental impact of chemical pesticides and fertilizers [2]. However, these biological products are not yet capable of fully replacing synthetic agricultural chemicals.The agricultural biologics market is projected to reach $16.61 billion in 2025, with a compound annual growth rate (CAGR) of 16.0% expected to push this value further to $29.92 billion by 2029 [2]. The growth is driven by factors such as the rise in organic farming practices, heightened awareness of the environmental impact of heavy chemical pesticide and fertilizer use, and an increase in the global population.
Syngenta, like many other major players in the agricultural biologics market, is actively innovating and introducing sustainable solutions. For instance, UK-based biotech firm Bionema UK launched the Biodegradable Surfactant Soil-Jet BSP100 in January 2024, which enhances the efficacy of biological and chemical products while minimizing environmental damage [2].
Despite the investments in biological products, Syngenta's operations are not expected to be significantly affected by the US tariffs. The company's focus on innovation and sustainability aligns with broader trends in the agricultural sector, where there is a growing preference for environmentally friendly solutions.
References:
[1] https://www.business-humanrights.org/en/latest-news/kenya-eu-based-companies-continue-to-export-banned-pesticides-exposing-communities-workers-to-chemical-burns-and-long-term-illness/
[2] https://menafn.com/1109644592/Global-Agricultural-Biologics-Market-Forecast-Key-Growth-Drivers-Trends-And-Opportunities-From-2025-To-2034
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet